Neelaveni Thangavel

4PUBLICATIONS
15CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 30, 2024
A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality.

Nem Kumar Jain, Mukul Tailang, Neelaveni Thangavel

|Mar 29, 2023
Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases.

Asim Najmi, Neelaveni Thangavel, Anugeetha Thacheril Mohanan

|Jul 05, 2022
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.

Mahmoud M Habibullah, Syam Mohan, Nabeel Kashan Syed

|Jun 29, 2017
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs.

Neelaveni Thangavel, Mohammed Al Bratty, Sadique Akhtar Javed

Pageof 1